Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
Frederick Johan Raal, Narimon Honarpour, Dirk Jacobus Blom, G. Kees Hovingh, Feng Xu, Robert C. Scott, Scott M. Wasserman, Evan A. Stein
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/s0140-6736(14)61374-x
- Published
- Oct 2, 2014
- Venue
- The Lancet
- DOI
- 10.1016/s0140-6736(14)61374-x
- PubMed
- 25282520
- Categories
- Lipoproteins and Cardiovascular Health
- Provenance
- openalex